Full-Spectrum phototherapy in hair loss management: a systematic review of wavelength-dependent mechanisms, clinical efficacy, and future directions.
Level 1 - systematic review of randomized trials
Indexed as a systematic review of phototherapy mechanisms and clinical efficacy in alopecia.
PubMed 40968340 · doi:10.1007/s10103-025-04616-3
What was done
The authors conducted a systematic review to synthesize wavelength-dependent photobiological mechanisms, clinical efficacy, and translational challenges of full-spectrum phototherapy (spanning ultraviolet to mid-infrared wavelengths) across hair loss conditions such as androgenetic alopecia, alopecia areata, and scarring alopecia. The abstract does not provide specific database search parameters, screening criteria, or the number of included studies.
What was found
The abstract reports no quantitative clinical trial data, sample sizes, or effect estimates. Qualitatively, the review describes wavelength-dependent biological actions: UVB/UVA light selectively induces T-cell apoptosis to restore immune privilege in alopecia areata; red light activates mitochondrial cytochrome c oxidase to stimulate dermal papilla cell proliferation in androgenetic alopecia and inhibit fibrosis in scarring alopecia; short-wavelength near-infrared light increases follicle angiogenesis and metabolic activity; and long-wavelength near-infrared to mid-infrared light triggers wound healing responses. Key clinical limitations noted include narrow therapeutic windows, variable patient responses, and limited light penetration into tissue.
Why it matters
This paper organizes full-spectrum light therapies into a target-mechanism model across specific alopecia subtypes, providing a conceptual framework to guide future protocol design such as dual-wavelength combinations and AI-driven parameter optimization.
Limits
The abstract contains no numerical outcome metrics, statistical comparisons, or quality assessments of the underlying studies. Mechanistic and cellular claims are presented together with clinical efficacy without distinguishing evidence from preclinical models versus controlled human clinical trials.
Cited by
- supports Long-wavelength light between approximately 620 nm and 850 nm from red light or near-infrared light devices penetrates deep into the skin.